Nippon India Pharma Fund - Direct (G) vs UTI-Flexi Cap Fund - Direct (G)

Nippon India Pharma Fund - Direct (G) vs UTI-Flexi Cap Fund - Direct (G)

stock1

Nippon India Pharma Fund - Direct (G)

7.4%

stock2

UTI-Flexi Cap Fund - Direct (G)

-1.01%

Loading chart...

About Fund

Deutsche Bank AG

Karvy Computershare Pvt. Ltd.

Stock Holding Corporation of India Limited Citibank NA HDFC Bank Limited

Computer Age Management Services Pvt Ltd.(CAMS) Datamatics Financial Software & services Limited Karvy Computershare Pvt. Ltd. UTI Technology Services Ltd.

Very High Risk

5000

9044.23

1.12

634.5023

January 1, 2013

1

Very High Risk

5000

22881.63

1.03

347.7652

January 1, 2013

0

14.01 %

19.35 %

7.4 %

6.79 %

9.07 %

-1.01 %

Sailesh Raj Bhan

MBA (Finance), CFA.

Mr.Bhan is an MBA with specialization in Finance and CFA. Has over 9 Yrs. of experience in Equity Securities Research & Sequeir Investment Pvt. Ltd. for 5 years and with Emkay Share & stock Broker Pvt. Ltd. for 2 years.

Ajay Tyagi

CFA,Master in Finance

Tyagi has done CFA Charter holder from The CFA Institute USA and Master in Finance from Delhi University. He has been working in equity research in UTI since 2000. He has also worked as Assistant Fund Manager in the Offshore Fund division.

Anoop Bhaskar

B.Com., MBA (Finance).

Prior to joining IDFC AMC, he was associated with UTI AMC (Apr 2007-Jan 2016), Sundaram AMC (Aug 2003-Mar 2007), Franklin Templeton AMC, Shriram Financial Services Ltd, Brisk Financial Services and Cross Borders Finance & Projects.

Get your FAQs right